Biden's Drug Pricing Administrative Actions Could Focus On Medicare Demos

Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.

New York, NY - January 7, 2020: Former Vice President & Democratic hopeful Joe Biden made foreign policy statement at Current on Pier 59
CAP Policies May Find Traction With Biden

Considering the options in the 2020 election, the pharma industry would probably vote for a split ticket: Joe Biden for President and Mitch McConnell for Senate majority leader, an outcome that would eliminate mercurial executive tweets on drug pricing, but retain a congressional bulwark against damaging pricing legislation.

But a Biden presidency would bring with it the threat of aggressive executive action on drug pricing – assuming any...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Elections

More from Legislation